A review in the Annals of Internal Medicine of 26 randomized controlled trials found that GLP-1 receptor agonists are safe and effective for weight loss in adults without diabetes, with the investigative treatment retatrutide leading to the most significant weight loss. Tirzepatide and semaglutide also showed substantial results.
Full Story: HealthDay News (1/7)